XML 45 R34.htm IDEA: XBRL DOCUMENT v3.7.0.1
Marketable Securities (Tables)
 12 Months Ended
Dec. 31, 2016
Schedule of Marketable Securities

Marketable securities consisted of the following as of December 31, 2016 (in thousands):

 

 

 

December 31, 2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost

 

 

Gross Unrealized Gains (Losses)

 

 

Gross Realized Gains (Losses)

 

 

Fair Value

 

Trading securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

      MedoveX common shares and warrants

 

$

              750

 

 

$

356

 

 

$

—

 

 

$

1,106

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2015

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost

 

 

Gross Unrealized Gains (Losses)

 

 

Gross Realized Gains (Losses)

 

 

Fair Value

 

Avaliable-for-sale securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

      NantKwest common shares and warrants

 

$

              10,000

 

 

$

87,366

 

 

$

—

 

 

$

97,366

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3)

The following table includes a summary of the contingent consideration liabilities associated with acquisitions entered into during the year ended December 31, 2016.  The contingent consideration is measured at fair value using significant unobservable inputs (Level 3) during the twelve months ended December 31, 2016: 

(in thousands)

 

2016

Fair Value at Beginning of Year

 

 

—

 

Contingent consideration – current year acquisitions

 

46,826

 

Remeasurement of Fair Value – current year acquisitions

 

(1,775)

 

Payment of current year contingent consideration

 

—

 

Balance at End of Year

 

$

45,052

 

The following table includes a summary of the derivative liabilities measured at fair value using significant unobservable inputs (Level 3) during the twelve months ended December 31, 2016.

(in thousands)

 

2016

Fair Value at Beginning of Year

 

$

5,520

 

 

Additions

 

—

 

 

Expiration of derivative liability

 

(5,520)

 

 

Payments

 

—

 

 

Balance at End of Year

 

$

—

 

 

 
Warrant [Member]  
Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3)

The following table includes a summary of the warrant measured at fair value using significant unobservable inputs (Level 3) during the twelve months ended December 31, 2016 (in thousands): 

 

 

 

 

 

Total

Beginning balance at December 31, 2015

 

 

$

—

  Addition of warrant

 

 

 

291

  Change in fair value of warrant

 

 

 

(16)

Ending balance at December 31, 2016

 

 

$

275